New International Heart Failure Guidelines
Posted on: Thursday, 14 September 2006, 18:01 CDT
The International Society for Heart and Lung Transplantation has unveiled the first ever international heart failure guidelines.
The suggested guidelines, released Thursday, are intended to assist doctors in the handling of heart failure patient management, particularly prior to heart transplantation.
Globally, there are about 12 million new cases of heart failure per year.
Comprehensive guidelines will help bridge the gap where current principles fall short and provide guidance to practicing physicians and cardiologists around the world, the society said.
Over the past decade, advancements in patient care with ventricular assist and other implantable devices, stem cell implants, biomedical developments and improved pharmaceutical management, have had a dramatic impact on care for heart failure patients, according to the society.
Taking these and other advancements into consideration, the new guidelines underscore the optimal process for managing heart failure patients prior to considering transplantation.
The final version of the guidelines, which appear in the September edition of the Journal of Heart and Lung Transplantation, are the result of a two-year deliberative process.
Source: United Press International
Related Articles
- Dallas Physician Elected to Lead International Organ Transplant Society
- Sernova Corp.'s Diabetes Technology Featured at International Congress of the Transplantation Society and on CTV National News
- Biomarkers May Reduce the Need for Biopsies and Offer Personalized Care for Heart and Lung Transplant Patients
- New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
- Independent Studies Report on Possible Roles for Cylex's Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
- Geron Scientists and Collaborators Demonstrate Human Embryonic Stem Cell-Derived Cardiomyocytes Improve Heart Function When Transplanted After Myocardial Infarction
- VentrAssist(TM) LVAD First 100 Patients - Clinical Data Presented at International Society of Heart and Lung Transplantation Meeting
- New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
- Abiomed to Showcase Circulatory Support Technologies at International Society for Heart and Lung Transplantation Meeting
- Affymetrix Microarrays Used to Detect Heart and Kidney Transplant Rejection Without Biopsy
 |
 |
User Comments (0)
RSS Feeds